II. Precautions
III. Indications
- See Hepatitis C Antiviral Regimen
- Salvage therapy after failure of other regimens
IV. Contraindications
- See Hepatitis C Antiviral Regimen
- Advanced Cirrhosis with Child Pugh Class B or C (or CTP score >=7)
V. Mechanism
- Similar to Epclusa, with addition of Voxilaprevir
- Sofosbuvir is a NS5B Polymerase Inhibitor (...buvirs)
- Velpatasvir is a NS5A Protein Inhibitor (...asvirs)
- Voxilaprevir is a NS3/4A Protease Inhibitor (...previrs)
VI. Evaluation
- See Hepatitis C Antiviral Regimen for Pre and post-treatment protocols
VII. Adverse Effects
VIII. Drug Interactions
- See Hepatitis C Antiviral Regimen
-
Sofosbuvir (Sovaldi) Drug Interactions
- See Sofosbuvir
- Avoid potent P-Glycoprotein Inducers (reduce Sofosbuvir efficacy)
- Avoid Amiodarone (severe Bradycardia risk)
- Velpatasvir Drug Interactions
-
Statins
- Avoid Rosuvastatin and Pitavastatin
- Limit Pravastatin to 40 mg daily
- Limit Atorvastatin to 10 mg daily
- Use lowest effective dose of other Statins
- Dabigatran
IX. Monitoring
X. Resources
XI. References
- (2023) Presc Lett, Hepatitis C Treatment Overview, Resource #390902